Acute intratracheal Pseudomonas aeruginosa infection in cystic fibrosis mice is age-independent
- Antje Munder†1Email author,
- Florian Wölbeling†1,
- Tanja Kerber-Momot2,
- Dirk Wedekind3,
- Ulrich Baumann4,
- Erich Gulbins5 and
- Burkhard Tümmler1, 4
© Munder et al; licensee BioMed Central Ltd. 2011
Received: 2 August 2011
Accepted: 7 November 2011
Published: 7 November 2011
Since the discovery of the human CFTR gene in 1989 various mouse models for cystic fibrosis (CF) have been generated and used as a very suitable and popular tool to approach research on this life-threatening disease. Age related changes regarding the course of disease and susceptibility towards pulmonary infections have been discussed in numerous studies.
Here, we investigated Cftr TgH(neoim)Hgu and Cftr tm1Unc -Tg(FABPCFTR)1Jaw/J CF mice and their non-CF littermates during an acute lung infection with Pseudomonas aeruginosa for age dependent effects of their lung function and immune response.
Mice younger than three or older than six months were intratracheally infected with P. aeruginosa TBCF10839. The infection was monitored by lung function of the animals using non-invasive head-out spirometry and the time course of physiological parameters over 192 hours. Quantitative bacteriology and lung histopathology of a subgroup of animals were used as endpoint parameters.
Age-dependent changes in lung function and characteristic features for CF like a shallower, faster breathing pattern were observed in both CF mouse models in uninfected state. In contrast infected CF mice did not significantly differ from their non-CF littermates in susceptibility and severity of lung infection in both mouse models and age groups. The transgenic Cftr tm1Unc -Tg(FABPCFTR)1Jaw/J and their non-CF littermates showed a milder course of infection than the Cftr TgH(neoim)Hgu CF and their congenic C57Bl/6J non-CF mice suggesting that the genetic background was more important for outcome than Cftr dysfunction.
Previous investigations of the same mouse lines have shown a higher airway susceptibility of older CF mice to intranasally applied P. aeruginosa. The different outcome of intranasal and intratracheal instillation of bacteria implies that infected CF epithelium is impaired during the initial colonization of upper airways, but not in the subsequent response of host defense.
KeywordsCystic fibrosis mouse models intranasal intratracheal experimental lung infection age effect
Cystic fibrosis (CF) is the most common life-shortening autosomal recessive disease within the Caucasian population and is caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene . The CFTR protein functions as a cAMP-regulated chloride channel in the apical membrane of epithelial cells. The symptoms of CF are caused by an impaired function of exocrine glands in many CFTR expressing organs, predominantly within the gastrointestinal and respiratory tracts. In most cases the progressive decrease of lung function is life limiting for CF patients. In this context, the opportunistic bacterial pathogen Pseudomonas aeruginosa most commonly causes chronic microbial lung infections, leading to excessive lung tissue remodelling and destruction [2, 3]. The bacteria are able to survive in the anaerobic environment of the CF lung  and become extremely resistant to the eradication of biofilms in the conducting airways by antibiotic treatment.
In 1989 the coding gene for the CF disease was identified on the long arm of chromosome 7 [5–7], a finding which highly advanced our understanding of CF cell biology and pathophysiology. In 1991 Tata et al.  and Yorifuji et al.  described the cloning and sequencing of the murine Cftr gene which is located in a conserved segment of chromosome 6 and shows 78% amino acid sequence homology to the human CFTR gene. Since no spontaneous mutations were known for the murine Cftr, different CF mouse models were generated by targeted mutagenesis . Most of these models show massive pathological changes in the intestine, but fail to develop a lung disease comparable to human CF subjects. The reason therefore may due to the short life expectancy of mice or their ability to use alternative chloride channels in the lung epithelium [11–15]. In 1992 Dorin and her coworkers described the Cftr TgH(neoim)Hgu mouse which only showed mild gastrointestinal complications, a good survival after weaning and benign respiratory symptoms [16, 17]. Another well described and often used mouse model is represented by the transgenic STOCK Cftr tm1Unc -Tg(FABPCFTR)1Jaw/J mouse, which expresses human CFTR in the gut under control of the FABP1 promoter (fatty acid binding protein1), which prevents it from acute intestinal obstruction .
Both CF models were included in a study by Teichgräber et al.  in which they detected ceramide accumulation in the murine respiratory epithelium and hypothesized that this accumulation leads to inflammation and cell death and increases infection susceptibility towards P. aeruginosa in CF patients. A significant increase of ceramide in the lung epithelium of both CF models was found to be associated with higher bacterial numbers, an accumulation of neutrophils and alveolar macrophages and increased cell death. All effects became more prominent with increasing age and started to become visible by around week 16 of murine life. These findings are also consistent with previously published data from P. Durie and associates, who identified many pathological changes in aged CF mice .
In this study described here we tested the influence of the described age-dependent ceramide accumulation  in our well established mouse model on airway infection with P. aeruginosa  using young and old mice and identical mouse strains but a different, namely intratracheal infection route. In Teichgräber's study  the bacteria were inoculated by intranasal instillation thus targeting both the upper and lower airways. In contrast intratracheal instillation  bypasses the upper airways and delivers more bacteria into distal bronchi than the intranasal inoculation. Thus the two infection routes target overlapping, but not matching airway compartments. We monitored the course of infection over 192 hours via several physiological parameters supported by non invasive head-out spirometry and employed quantitative bacteriology and lung histopathology as endpoint parameters. To make a clear distinction we categorized mice in groups younger than three and older than six months. Moreover, we compared the lung function of the CF mice in the uninfected state. The differential outcome of the infection experiments in Teichgräber's and our study led to the conclusion that older CF mice are impaired in their first defence of bacterial clearance, but that otherwise the clinical course of the acute P. aeruginosa lung infection is indistinguishable between CF and non-CF mice that share the same genetic background.
Infection experiments were performed with two CF mouse models (a) B6.129P2(CF/3)-Cftr TgH(neoim)Hgu , (b) Cftr tm1Unc -Tg(FABPCFTR)1Jaw/J and their respective littermates. According to the nomenclature of Teichgräber et al. the mouse lines are called (a) Cftr MHH and (b) Cftr KO , their non-CF littermates (a) B6 and (b) WT, respectively. In Cftr TgH(neoim)Hgu mice the exon 10 of the Cftr gene had been disrupted by the insertion of the vector pMCIneoPolyA . Since those mice produced low levels of Cftr  but showed a mixed genetic background , from the original Cftr TgH(neoim)Hgu mutant mouse, CF strain CF/3-Cftr TgH(neoim)Hgu was established at the Institute of Laboratory Animal Science of the Hannover Medical School by brother-sister mating for more than 40 generations. Next, the congenic mouse inbred strain B6.129P2(CF/3)- Cftr TgH(neoim)Hgu , which is used in this study, was generated by 40 backcross generations using CF/3-Cftr TgH(neoim)Hgu as donor strain and C57BL/6J as recipient strain . Following the nomenclature of Teichgräber et al.  this strain is called Cftr MHH , syngenic C57BL6/J mice are called B6 and served as controls. Cftr MHH mice are regulary monitored for their congenic C57BL/6J status using 27 SNP markers and integrity of the mutant Cftr locus by intragenic microsatellite markers [24, 26, 27].
STOCK Cftr tm1Unc -Tg(FABPCFTR)1Jaw/J mice were obtained from the Jackson Laboratories. These mice, in the following called Cftr KO , which are of a mixed genetic background consisting of C57BL/6, FVB/N and 129, are knock-outs for the murine Cftr gene, but express human CFTR in the gut under control of the FABP1 (fatty acid binding protein1) promoter, which prevents acute intestinal obstruction 1 [12, 18]. Mice were obtained homozygous and heterozygous for the Cftr tm1Unc targeted mutation (tm/tm and tm/+) as well as homozygous and hemizygous for the FABP-hCFTR transgene (tg/tg and tg/0). Tm/+ tg/0 mice were used as parents to generate wildtype control mice (called WT). Genotyping was performed using the protocols provided by the JAX lab .
Mice were maintained at the Central Animal Facility of the Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. They were held in groups of three to five animals animals in microisolator cages (910 cm2) with filter top lids and free access to sterilised standard laboratory chow (diet No. 1324, Altromin, Lippe, Germany) and autoclaved, acidulated water at 21 ± 2°C, 55 ± 5% humidity and a 10:14 light-dark-cycle. None of the CF mice showed gastrointestinal complications which would require a special diet. All mice were regularly monitored for infection by typical pathogens according to the FELASA recommendations . All procedures performed on mice were approved by the local district governments (AZ. 33.9-42502-04-08/1528) and carried out according to the ILAR guidelines for the care and use of laboratory animals . Experimental groups of mice were allocated by age of either younger than three (henceforth designated as young) or elder than six months (henceforth designated as old). This selection aimed to mimic the categories of Teichgräber et al.  that mice older than 4 months were susceptible to an infection with P. aeruginosa whereas the younger mice were more or less resistant.
Due to breeding limitations B6 mice showed a strong predominance of males and no 192 h value of old B6 exist.
Non-invasive head-out spirometry with 14 parameters was performed on conscious restrained mice . In brief, four mice were investigated in parallel by placing them in glass inserts with their heads protruding out through a set of membranes ensuring an airtight fit. Respiration caused air to flow through a pneumotachograph positioned above the thorax of the animals. The airflow was digitalized and analyzed with the Notocord Hem 220.127.116.11 software package (Notocord Systems SAS, Croissy Sur Seine, France).
Pseudomonas aeruginosa strain TBCF10839  was grown in Luria broth (LB) overnight at 37°C. The overnight culture was washed twice with the same volume of sterile PBS to remove cell detritus and secreted exopolysaccharides, then the optical density of the bacterial suspension was determined and the intended number of colony forming units (CFU) was extrapolated from a standard growth curve. Inocula with 6.0 × 105 CFU in 30 μl were prepared by dilution with sterile PBS. This infection dose is approximately one tenth of the LD50 of strain TBCF10839 for C57BL/6J mice and was able to produce a clinical infection without mortality.
Mice were infected intratracheally (i.t.) with 6.0 × 105 CFU of P. aeruginosa strain TBCF10839 under a light anaesthesia. For detailed description of the view-controlled intratracheal instillation see Munder et al. . To characterize the course of the bacterial infection, the body condition, weight, rectal temperature and lung function of the mice were evaluated as described previously . In brief the overall health of the animals was assessed by vocalisation, piloerection, posture, locomotion, breathing, curiosity, nasal secretion, grooming and dehydration. Dysfunctions in single parameters were assessed by zero, one or two points. The overall fitness of the mice was determined by adding the points resulting in the following score of the mouse body condition: unaffected (0-1); slightly affected (2-4); moderately affected (5-7); severely affected (8-10); moribund (≥ 11).
Non-invasive head-out spirometry. First, spirometric values of uninfected animals (B6, WT, Cftr KO and Cftr MHH with age young: < 99 days and old: > 179 days) were averaged (median) from three independent measurements preformed on consecutive days. Prior measurements assured that the mice had adapted to the procedure. Lung function measurements of infection experiments were taken daily at the five days prior to inoculation and at time points 4, 6, 8, 10, 12, 18, 24, 48, 72, 96, 120, 144, 168, 192 hours post inoculation.
Forty-eight hours after challenge subgroups of mice were euthanized. Their left lungs were taken for the determination of bacterial counts and the right lungs were stained and examined histologically.
Pathohistology of the lungs
The right lungs were fixed via the trachea (4% paraformaldehyd), embedded in paraffin and stained with haematoxilin/eosin. One section was selected that showed aspects from all three lobes of the right lung. This slide was examined in twenty fields of view at a 100 fold magnification using a Zeiss Axiophot photomicroscope. Inflammation was assessed using a semi quantitative pathohistological score . Shortly, lung histological changes were scored on a scale from one to three points. Points were given separately for lung parenchyma, airways and lung vessels. The total score classified airway inflammation into the categories: almost not visible (0-5); slight (6-20) moderate (21-40); severe/profound inflammation (41-60). In the current study no more than a medium-grade inflammation was seen, appearing as a purulent alveolar pneumonia with peribronchiolar and perivascular inflammatory infiltrates.
Lung bacterial numbers
The left lungs of the euthanized mice were ligated, resected and homogenised. Aliquots were plated and bacterial numbers of whole organs were calculated. Previous experiments showed that the distribution of bacteria is approximately equal in left and right lungs after i.t. application (data not shown).
Each CF mouse model and its wild type controls were investigated separately by age group using non-parametric test statistics of SPSS 16 (Version 16.0.2, SPSS Inc, Chicago, USA). p-values (p < 0.05) with subsequent Bonferroni correction were calculated by 2-sided Monte Carlo simulations (100,000 simulations). Hereby groups were composed of equal numbers of mice (perfect match approach).
Lung function of CF mice
Tidal volume increased with age of the animals reflecting an increase in body mass. Respiration decreased, also characterized by increasing times for one breath. The slower breathing was also characterized by a decrease in the flows of expiration and inspiration.
Body weight measurements showed that Cftr KO and WT mice were slightly larger and heavier than Cftr MHH and B6 mice. This is mirrored in a slightly higher tidal volume for the Cftr KO and WT mice.
All mice irrespective of genotype or gender had a comparable total lung volume (tidal volume, Figure 1A). CF mice, however, achieved the comparable lung volume through an increase in respiratory rate (Figure 1B). Correspondingly the time for one breath (Time of inspiration plus expiration, Figure 1C) was smaller in CF mice. The higher respiratory rate was associated with higher flows as depicted by the EF50 parameter (Midtidal expiratory flow at 50% expiration, Figure 1D).
Outline of infection experiments
Global body condition
B6 mice were more affected by P. aeruginosa in their body condition than the Cftr KO and their non-CF littermates (Figure 2). With the exception of young Cftr KO mice the corresponding CF and non-CF mouse lines exhibited a similar time course of disease symptoms. Animals were notably affected between 6-12 h after inoculation and recovered within the next 48 h. Young WT mice were least affected by the instillation of P. aeruginosa into their lungs.
Rectal body temperature
Upon exposure to bacteria mice did not react with fever but with a drop of body temperature. The temperature profile mimicked the time course of the global health score. Cftr MHH and the B6 mice experienced a stronger drop of temperature than the Cftr KO and WT mice, the latter being minimally affected with a maximal reduction of rectal temperature of 5°C (Figure 3).
Within the first 24 h post inoculation the mice lost 8% (old B6) to 13% (young Cftr MHH ) of their initial body weight (Figure 4). By the end of the experiment the young mice had almost completely regained their initial weight, whereas an irreversible weight loss was observed in all old mice. Consistent with an intestinal CF phenotype, old Cftr MHH mice were significantly lighter than their congenic B6 mice .
The time course during infection is shown exemplarily for tidal volume (the total volume inspired and expired in one breath) (Figure 5A, B), Time of inspiration plus expiration (Figure 5C, D) and EF50 (Figure 5E, F). The data of all 14 measured lung function parameters are shown in the online supplement (Additional file 1). The old non-CF and CF mice showed a similar response in lung function towards the instillation of P. aeruginosa into their lungs. Young KO mice differed from their WT FABP littermates in a shorter 'time of pause' prior to and after inoculation, but not in any other of the 14 parameters. In contrast, non-infected young Cftr MHH mice showed another breathing pattern than their congenic B6 mice (see above). Cftr MHH mice differed from their non-CF congenics in seven lung function parameters with a high respiratory rate as the leading symptom. This characteristic pattern of non-infected Cftr MHH mice was also seen in the challenged mice at the late time points of 144, 168 and 192 h when they had recovered from infection. Thus, by the end of experiment the Cftr MHH mice had regained the initial lung function phenotype. Besides these CF-genotype-driven differences between congenic mice that were apparently independent of bacterial infection, a differential response of Cftr MHH and B6 mice was noted at time points 4 and 6 hours after challenge with P. aeruginosa. Lung function slightly, but significantly differed in seven flow or volume parameters (Additional file 1). In summary, differences in lung function between congenic non-CF and CF mice were not detectable or subtle, and if they were more prominent as in the case of Cftr MHH mice, they were also existent in non-infected animals.
This study shows for the first time lung function data of CF mice and demonstrates the impact of age, cftr genotype, genetic background and an acute airway infection with P. aeruginosa on lung function. Lung function measurements in uninfected CF and non-CF mice showed general trends for the investigated age groups. Tidal volume increased slightly with increased body weight. Respiratory rate decreased as mice breathe slower, which is also observed in the time required for one breath. In general the flows also decreased concordant with the slower respiration. CF and wild type mice had approximately the same tidal volume. However, when further lung function parameters were taken into account, it could be observed that the tidal volume levels of the CF mice were only achieved through faster breathing as characterized by the times for breathing and the respiratory rate. Interestingly these variations between CF and non-CF mice of the same genetic background did not withstand under P. aeruginosa airway infection.
Chronic airway infections with P. aeruginosa contribute substantially to morbidity and mortality in individuals with CF [33, 34]. Numerous infection models have been established in rodents to mimick the P. aeruginosa infection in CF, but only the rather artificial bead models with encapsulated P. aeruginosa partially succeeded to mimick bacterial persistence in lungs that is typical for human CF airways [35–37]. No chronic P. aeruginosa infection model has yet been established in CF mice [10, 14, 15]. This fact may be ascribed to differences in lung morphology or lung physiology such as the lack of submucosal glands in the lower conducting airways of the mouse or to the endogeneous expression of alternative chloride channels in murine lungs that may at least in part rescue loss-of-function Cftr [11, 38]. Although the former argument is probably true and hence calls for alternative infection models in the recently developed CF pigs and CF ferrets [39–45], the latter argument is less convincing because we meanwhile know of many CF patients who express residual amounts of CFTR or alternative ion conductances and still become chronically colonized with P. aeruginosa in their airways [46, 47]. Hence we propose that we should revisit the CF mouse infection models and try to pinpoint concordant and discordant mechanisms that are operating in CF mice and CF patients.
Only recently a link between Cftr genotype and the airway infection with P. aeruginosa in mice could be established. CF mice elder than 16 weeks became susceptible to airway colonization with P. aeruginosa when infected by the intranasal route . This phenotype was associated with an age-dependent accumulation of ceramide in airway epithelial cells. When ceramide accumulation was prevented by pharmacological or genetic means, the CF mice lost their increased susceptibility to colonization with P. aeruginosa.
For the present study we selected exactly the same CF mouse lines and their congenic or transgenic controls, but inoculated P. aeruginosa by intratracheal instillation . The congenic B6 mice showed more pronounced symptoms of acute infection than the transgenic mice, but non-CF and CF animals with the same genetic background behaved more or less similar. The old CF mice were not more susceptible to P. aeruginosa infection than their age-matched wild type controls.
We have previously investigated the CF phenotype of trachea and upper airways of Cftr MHH mice [21, 25]. Like in humans, the nasal epithelium of the CF mice exhibited the basic defect of Na+ hyperabsorption and Cl- hyposecretion  and the trachea had accumulated ceramide . The basic defect of perturbed electrolyte transport across the apical epithelial membrane translates into airway surface dehydration and impaired mucociliary clearance , and we have indeed measured impaired clearance in Cftr MHH mice . Correspondingly, if CF mice were exposed intranasally with P. aeruginosa the bacterial clearance did not work efficiently in the upper airways of CF mice and the bacterial load increased within the first hours . In contrast, if the murine lung was inoculated with P. aeruginosa by intratracheal instillation, the bacterial clearance from the upper airways and the large conducting lower airways was bypassed and the host response to the intratracheal infection route was indistinguishable between congenic CF and non-CF mice. Thus we would like to conclude that the CF condition undermines the first barrier of host defense, i.e. bacterial clearance, but does not compromise the subsequent host responses. This conclusion fits with our current knowledge of how the basic defect in CF patients predisposes to infection in conducting airways [40, 48, 50, 51]: CFTR-deficiency impairs ciliary clearance and slows down mucus transport thus facilitating bacterial colonization, particularly if the airways are injured by an acute viral infection .
Hence, the bottom-line of our previous and present studies is that CF mice are suited to investigate of how the basic defect translates into an increased susceptibility to airway colonization with P. aeruginosa. The first line of host defense, i.e. the removal of bacteria from the airways by mucociliary clearance is deficient in CF mice. However, the subsequent steps of host-pathogen interaction during an acute infection with P. aeruginosa are not compromised in CF mice. In other words, CF mice are appropriate models to study the very early host defense mechanisms.
The authors are indebted to Achim Gruber's laboratory for the preparation and staining of the histological samples. We also thank Damaris Leemhuis and Sylwia Wiehlmann for excellent technical assistance and to Dagmar Stelte for her excellent editing of the sketch.
This work was supported by a grant of the Deutsche Forschungsgemeinschaft to BT (SFB 587, project A9). FW received a predoctoral stipend from the DFG-supported IRTG ‚Pseudomonas: Pathogenicity and Biotechnology' (GRK 653/3 and 653/4). Publication was supported by the 'Open Access Publishing' project of the Deutsche Forschungsgemeinschaft.
- Ratjen F, Döring G: Cystic fibrosis. Lancet. 2003, 361: 681-689. 10.1016/S0140-6736(03)12567-6.View ArticlePubMedGoogle Scholar
- Davis PB, Drumm M, Konstan MW: Cystic fibrosis. Am J Respir Crit Care Med. 1996, 154: 1229-1256.View ArticlePubMedGoogle Scholar
- Gibson RL, Burns JL, Ramsey BW: Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 2003, 168: 918-951. 10.1164/rccm.200304-505SO.View ArticlePubMedGoogle Scholar
- Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Döring G: Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest. 2002, 109: 317-325.PubMed CentralView ArticlePubMedGoogle Scholar
- Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N: Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989, 245: 1059-1065. 10.1126/science.2772657.View ArticlePubMedGoogle Scholar
- Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Tsui LC: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989, 245: 1066-73. 10.1126/science.2475911.View ArticlePubMedGoogle Scholar
- Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC: Identification of the cystic fibrosis gene: genetic analysis. Science. 1989, 245: 1073-1080. 10.1126/science.2570460.View ArticlePubMedGoogle Scholar
- Tata F, Stanier P, Wicking C, Halford S, Kruyer H, Lench NJ, Scambler PJ, Hansen C, Braman JC, Williamson R: Cloning the mouse homolog of the human cystic fibrosis transmembrane conductance regulator gene. Genomics. 1991, 10: 301-307. 10.1016/0888-7543(91)90312-3.View ArticlePubMedGoogle Scholar
- Yorifuji T, Lemna WK, Ballard CF, Rosenbloom CL, Rozmahel R, Plavsic N, Tsui LC, Beaudet AL: Molecular cloning and sequence analysis of the murine cDNA for the cystic fibrosis transmembrane conductance regulator. Genomics. 1991, 10: 547-550. 10.1016/0888-7543(91)90434-G.View ArticlePubMedGoogle Scholar
- Grubb BR, Boucher RC: Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev. 1999, 79: 193-214.Google Scholar
- Rozmahel R, Wilschanski M, Matin A, Plyte S, Oliver M, Auerbach W, Moore A, Forstner J, Durie P, Nadeau J, Bear C, Tsui LC: Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet. 1996, 12: 280-287. 10.1038/ng0396-280.View ArticlePubMedGoogle Scholar
- Haston CK, McKerlie C, Newbigging S, Corey M, Rozmahel R, Tsui LC: Detection of modifier loci influencing the lung phenotype of cystic fibrosis knockout mice. Mamm Genome. 2002, 13: 605-13. 10.1007/s00335-002-2190-7.View ArticlePubMedGoogle Scholar
- Kent G, Iles R, Bear CE, Huan LJ, Griesenbach U, McKerlie C, Frndova H, Ackerley C, Gosselin D, Radzioch D, O'Brodovich H, Tsui LC, Buchwald M, Tanswell AK: Lung disease in mice with cystic fibrosis. J Clin Invest. 1997, 100: 3060-3069. 10.1172/JCI119861.PubMed CentralView ArticlePubMedGoogle Scholar
- Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, Koller BH: An animal model for cystic fibrosis made by gene targeting. Science. 1992, 257: 1083-1088. 10.1126/science.257.5073.1083.View ArticlePubMedGoogle Scholar
- Snouwaert JN, Brigman KK, Latour AM, Iraj E, Schwab U, Gilmour MI, Koller BH: A murine model of cystic fibrosis. Am J Respir Crit Care Med. 1995, 151: 59-64.View ArticleGoogle Scholar
- Dorin JR, Dickinson P, Alton EWFW, Smith SN, Geddes DM, Stevenson BJ, Kimber WL, Fleming S, Clarke AR, Hooper ML, Anderson L, Beddington RSP, Porteous DJ: Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature. 1992, 359: 211-215. 10.1038/359211a0.View ArticlePubMedGoogle Scholar
- Dorin JR, Stevenson BJ, Fleming S, Alton EW, Dickinson P, Porteous DJ: Long-term survival of the exon 10 insertional cystic fibrosis mutant mouse is a consequence of low level residual wild-type Cftr gene expression. Mamm Genome. 1994, 5: 465-472. 10.1007/BF00369314.View ArticlePubMedGoogle Scholar
- Zhou L, Dey CR, Wert SE, DuVall MD, Frizzell RA, Whitsett JA: Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science. 1994, 266: 1705-1708. 10.1126/science.7527588.View ArticlePubMedGoogle Scholar
- Teichgräber V, Ulrich M, Endlich N, Riethmüller J, Wilker B, De Oliveira-Munding CC, van Heeckeren AM, Barr ML, von Kürthy G, Schmid KW, Weller M, Tümmler B, Lang F, Grassme H, Döring G, Gulbins E: Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med. 2008, 14: 382-391. 10.1038/nm1748.View ArticlePubMedGoogle Scholar
- Durie PR, Kent G, Phillips MJ, Ackerley CA: Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model. Am J Pathol. 2004, 164: 1481-1493. 10.1016/S0002-9440(10)63234-8.PubMed CentralView ArticlePubMedGoogle Scholar
- Becker KA, Tümmler B, Gulbins E, Grassmé H: Accumulation of ceramide in the trachea and intestine of cystic fibrosis mice causes inflammation and cell death. Biochem Biophys Res Commun. 2010, 403: 368-74. 10.1016/j.bbrc.2010.11.038.View ArticlePubMedGoogle Scholar
- Wölbeling F, Munder A, Stanke F, Tümmler B, Baumann U: Head-out spirometry accurately monitors the course of Pseudomonas aeruginosa lung infection in mice. Respiration. 2010, 80: 340-346.PubMedGoogle Scholar
- Munder A, Krusch S, Tschernig T, Dorsch M, Lührmann A, van Griensven M, Tümmler B, Weiss S, Hedrich HJ: Pulmonary microbial infection in mice: Comparison of different application methods and correlation of bacterial numbers and histopathology. Exp Toxicol Pathol. 2002, 54: 127-133. 10.1078/0940-2993-00240.View ArticlePubMedGoogle Scholar
- Charizopoulou N, Jansen S, Dorsch M, Stanke F, Dorin JR, Hedrich HJ, Tümmler B: Instability of the insertional mutation CftrTgH(neoim)Hgu cystic fibrosis mouse model. BMC Genetics. 2004, 5: 6-PubMed CentralView ArticlePubMedGoogle Scholar
- Tóth B, Wilke M, Stanke F, Dorsch M, Jansen S, Wedekind D, Charizopoulou N, Bot A, Burmester M, Leonhard-Marek S, de Jonge HR, Hedrich HJ, Breves G, Tümmler B: Very mild disease phenotype of congenic CftrTgH(neoim)Hgu cystic fibrosis mice. BMC Genetics. 2008, 9: 28-PubMed CentralView ArticlePubMedGoogle Scholar
- Petkov PM, Cassell MA, Sargent EE, Donnelly CJ, Robinson P, Crew V, Asquith S, Haar RV, Wiles MV: Development of a SNP genotyping panel for genetic monitoring of the laboratory mouse. Genomics. 2004, 83: 902-11. 10.1016/j.ygeno.2003.11.007.View ArticlePubMedGoogle Scholar
- Hedrich HJ, Rapp KG, Zschege C: Genetic constancy, respectively subline drifting of inbred strains of rats and mice. Z Versuchstierkd. 1975, 17: 263-74.PubMedGoogle Scholar
- The JAX® Mice Database. [http://jaxmice.jax.org/strain/002364.html]
- Nicklas W, Baneux P, Boot R, Decelle T, Deeny AA, Fumanelli M, Illgen-Wilcke B, FELASA (Federation of European Laboratory Animal Science Associations Working Group on Health Monitoring of Rodent and Rabbit Colonies). FELASA, London UK: Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Anim. 2002, 36: 20-42. 10.1258/0023677021911740.View ArticlePubMedGoogle Scholar
- National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals: Guide for the Care and Use of Laboratory Animals. 2011, National Academies Press (US), Washington (DC), 8Google Scholar
- Tümmler B, Koopmann U, Grothues D, Weissbrodt H, Steinkamp D, von der Hardt H: Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients. J Clin Microbiol. 1991, 29: 1265-1267.PubMed CentralPubMedGoogle Scholar
- Munder A, Zelmer A, Schmiedl A, Dittmar KE, Rohde M, Dorsch M, Otto K, Hedrich HJ, Tümmler B, Weiss S, Tschernig T: Murine pulmonary infection with Listeria monocytogenes: differential susceptibility of BALB/c, C57BL/6 and DBA/2 mice. Microbes Infect. 2005, 7: 600-611. 10.1016/j.micinf.2004.12.021.View ArticlePubMedGoogle Scholar
- Saiman L: Microbiology of early CF lung disease. Paediatr Respir Rev. 2004, 5 (Suppl A): 367-369.View ArticleGoogle Scholar
- Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, Collins J, Rock MJ, Splaingard ML: Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA. 2005, 293: 581-588. 10.1001/jama.293.5.581.View ArticlePubMedGoogle Scholar
- Cash HA, Woods DE, McCullough B, Johanson WG, Bass JA: A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis. 1979, 119: 453-459.PubMedGoogle Scholar
- O'Reilly T: Relevance of animal models for chronic bacterial infections in humans. Am J Respir Crit Care Med. 1995, 151: 2101-2107.View ArticlePubMedGoogle Scholar
- Pedersen SS, Shand GH, Hansen BL, Hansen GN: Induction of experimental chronic Pseudomonas aeruginosa lung infection with P. aeruginosa entrapped in alginate microspheres. APMIS. 1990, 98: 203-211. 10.1111/j.1699-0463.1990.tb01023.x.View ArticlePubMedGoogle Scholar
- Guilbault C, Saeed Z, Downey GP, Radzioch D: Cystic fibrosis mouse models. Am J Respir Cell Mol Biol. 2007, 36: 1-7.View ArticlePubMedGoogle Scholar
- Rogers CS, Stoltz DA, Meyerholz DK, Ostedgaard LS, Rokhlina T, Taft PJ, Rogan MP, Pezzulo AA, Karp PH, Itani OA, Kabel AC, Wohlford-Lenane CL, Davis GJ, Hanfland RA, Smith TL, Samuel M, Wax D, Murphy CN, Rieke A, Whitworth K, Uc A, Starner TD, Brogden KA, Shilyansky J, McCray PB, Zabner J, Prather RS, Welsh MJ: Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science. 2008, 321: 1837-1841. 10.1126/science.1163600.PubMed CentralView ArticlePubMedGoogle Scholar
- Lee RJ, Foskett JK: cAMP-activated Ca2+ signaling is required for CFTR-mediated serous cell fluid secretion in porcine and human airways. J Clin Invest. 2010, 120: 3137-3148. 10.1172/JCI42992.PubMed CentralView ArticlePubMedGoogle Scholar
- Joo NS, Cho HJ, Khansaheb M, Wine JJ: Hyposecretion of fluid from tracheal submucosal glands of CFTR-deficient pigs. J Clin Invest. 2010, 120: 3161-3166. 10.1172/JCI43466.PubMed CentralView ArticlePubMedGoogle Scholar
- Rogan MP, Reznikov LR, Pezzulo AA, Gansemer ND, Samuel M, Prather RS, Zabner J, Fredericks DC, McCray PB, Welsh MJ, Stoltz DA: Pigs and humans with cystic fibrosis have reduced insulin-like growth factor 1 (IGF1) levels at birth. Proc Natl Acad Sci USA. 2010, 107: 20571-5. 10.1073/pnas.1015281107.PubMed CentralView ArticlePubMedGoogle Scholar
- Chen JH, Stoltz DA, Karp PH, Ernst SE, Pezzulo AA, Moninger TO, Rector MV, Reznikov LR, Launspach JL, Chaloner K, Zabner J, Welsh MJ: Loss of anion transport without increased sodium absorption characterizes newborn porcine cystic fibrosis airway epithelia. Cell. 2010, 143: 911-23. 10.1016/j.cell.2010.11.029.PubMed CentralView ArticlePubMedGoogle Scholar
- Ostedgaard LS, Meyerholz DK, Chen JH, Pezzulo AA, Karp PH, Rokhlina T, Ernst SE, Hanfland RA, Reznikov LR, Ludwig PS, Rogan MP, Davis GJ, Dohrn CL, Wohlford-Lenane C, Taft PJ, Rector MV, Hornick E, Nassar BS, Samuel M, Zhang Y, Richter SS, Uc A, Shilyansky J, Prather RS, McCray PB, Zabner J, Welsh MJ, Stoltz DA: The ΔF508 mutation causes CFTR misprocessing and cystic fibrosis-like disease in pigs. Sci Transl Med. 2011, 3: 74ra24-10.1126/scitranslmed.3001868.PubMed CentralView ArticlePubMedGoogle Scholar
- Sun X, Sui H, Fisher JT, Yan Z, Liu X, Cho HJ, Joo NS, Zhang Y, Zhou W, Yi Y, Kinyon JM, Lei-Butters DC, Griffin MA, Naumann P, Luo M, Ascher J, Wang K, Frana T, Wine JJ, Meyerholz DK, Engelhardt JF: Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J Clin Invest. 2010, 120: 3149-3160. 10.1172/JCI43052.PubMed CentralView ArticlePubMedGoogle Scholar
- Kubesch P, Dörk T, Wulbrand U, Kälin N, Neumann T, Wulf B, Geerlings H, Weissbrodt H, von der Hardt H, Tümmler B: Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis. Lancet. 1993, 341: 189-193. 10.1016/0140-6736(93)90062-L.View ArticlePubMedGoogle Scholar
- Kumar V, Becker T, Jansen S, van Barneveld A, Boztug K, Wölfl S, Tümmler B, Stanke F: Expression levels of FAS are regulated through an evolutionary conserved element in intron 2, which modulates cystic fibrosis disease severity. Genes Immun. 2008, 9: 689-696. 10.1038/gene.2008.63.View ArticlePubMedGoogle Scholar
- Boucher RC: Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med. 2007, 58: 157-70. 10.1146/annurev.med.58.071905.105316.View ArticlePubMedGoogle Scholar
- Larbig M, Jansen S, Dorsch M, Bernhard W, Bellmann B, Dorin JR, Porteous DJ, Von Der Hardt H, Steinmetz I, Hedrich HJ, Tuemmler B, Tschernig T: Residual cftr expression varies with age in cftr(tm1Hgu) cystic fibrosis mice: impact on morphology and physiology. Pathobiology. 2002, 70: 89-97. 10.1159/000067308.View ArticlePubMedGoogle Scholar
- Choi JY, Joo NS, Krouse ME, Wu JV, Robbins RC, Ianowski JP, Hanrahan JW, Wine JJ: Synergistic airway gland mucus secretion in response to vasoactive intestinal peptide and carbachol is lost in cystic fibrosis. J Clin Invest. 2007, 117: 3118-3127. 10.1172/JCI31992.PubMed CentralView ArticlePubMedGoogle Scholar
- Joo NS, Cho HJ, Khansaheb M, Wine JJ: Hyposecretion of fluid from tracheal submucosal glands of CFTR-deficient pigs. J Clin Invest. 2010, 120: 3161-3166. 10.1172/JCI43466.PubMed CentralView ArticlePubMedGoogle Scholar
- Wang EEL, Prober CG, Manson B, Corey M, Levison H: Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med. 1984, 311: 1653-1658. 10.1056/NEJM198412273112602.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.